Skip to main content

Table 2 Valid the promoting blood circulation activity of vinegars in vivo

From: Application of a strategy based on metabolomics guided promoting blood circulation bioactivity compounds screening of vinegar

Groups WBV PV TT (s) PT (s) FIB (g L−1) APTT (s) ESR PCV
1 3 30 100 200
N 11.06 ± 1.12 8.18 ± 1.15 4.69 ± 0.25 3.63 ± 0.19 3.16 ± 0.15 1.45 ± 0.06 28.77 ± 4.20 9.80 ± 0.30 1.76 ± 0.22 12.93 ± 0.94 0.62 ± 0.75 44.10 ± 3.17
M 23.52 ± 3.12** 13.51 ± 1.60** 6.25 ± 0.45** 4.76 ± 0.50** 3.85 ± 0.24** 1.66 ± 0.07** 24.60 ± 1.22* 8.50 ± 0.37** 5.59 ± 0.45** 10.07 ± 0.72** 2.83 ± 2.32** 51.87 ± 5.53**
W 28.74 ± 2.01 15.93 ± 0.96 6.23 ± 0.88 5.23 ± 0.20 4.18 ± 0.16 1.64 ± 0.03 36.88 ± 2.83## 8.92 ± 0.25 5.58 ± 0.44 14.26 ± 0.55# 1.72 ± 1.23 48.48 ± 2.85
RL 23.83 ± 2.85 13.30 ± 1.03 6.07 ± 0.33 4.48 ± 0.38 3.77 ± 0.17 1.52 ± 0.07## 40.88 ± 3.78## 9.15 ± 0.33## 5.41 ± 0.45 14.37 ± 1.07# 1.80 ± 1.15 50.66 ± 2.01
RH 23.70 ± 2.69 13.71 ± 1.14 6.10 ± 0.19 4.52 ± 0.32 3.78 ± 0.14 1.51 ± 0.06## 37.72 ± 3.45## 9.66 ± 0.35## 4.64 ± 0.32## 15.68 ± 1.41## 1.30 ± 1.12# 52.07 ± 3.09
AER 18.71 ± 2.54## 11.69 ± 1.52# 5.72 ± 0.35# 4.16 ± 0.22## 3.54 ± 0.20## 1.51 ± 0.05## 39.37 ± 4.98## 9.43 ± 0.51## 5.26 ± 0.66# 13.55 ± 1.29# 0.63 ± 0.73## 45.42 ± 3.22##
TMPZ 23.24 ± 2.80 13.57 ± 1.25 6.03 ± 0.42 4.47 ± 0.49 3.74 ± 0.21 1.57 ± 0.05# 35.12 ± 4.13## 9.02 ± 0.25# 5.54 ± 0.83 15.45 ± 0.55 1.00 ± 0.88# 47.98 ± 2.02
Asp 18.89 ± 1.70# 12.51 ± 1.27# 5.86 ± 0.26# 4.13 ± 0.07## 3.52 ± 0.10## 1.53 ± 0.10# 38.20 ± 2.01## 9.35 ± 0.44## 4.68 ± 0.34## 15.37 ± 0.81# 0.58 ± 0.88## 46.72 ± 3.93##
  1. Data represent mean ± SD n = 8
  2. N Normal group, M Model group, W WV group, RL RV low dosage group, RH RV high dosage group, AER0 Alkaloid extraction of RV
  3. * p < 0.05 vs. control group
  4. ** p < 0.01 vs. control group
  5. #p < 0.05 vs. model group
  6. ##p < 0.01 vs. model group